Want to join the conversation?
Diagnostic products maker $BDX's 1Q16 revenues grew 1.8%, which is in line with the prior guidance of 1-2% growth, reflecting solid underlying growth in Medical and Life Sciences segments. Adjusted EPS was $1.96, helped by solid underlying performance of the segments and earnings were ahead of the company's expectations.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!